Assay Interference by Aggregation

Review

In: Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004.

2017 Jul 26.

Douglas S. Auld¹, James Inglese^{2

3}, Jayme L. Dahlin⁴

¹ Novartis Institutes for Biomedical Research, Cambridge, MA, USA
² National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA
³ National Human Genome Research Institute, Bethesda, MD, USA
⁴ Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA

¹ National Center for Advancing Translational Sciences, National Institutes of Health
² University of California, San Francisco
³ Novartis Institutes for Biomedical Research
⁴ GSK plc
⁵ Lyterian Therapeutics
⁶ Sanford Burnham Prebys Medical Discovery Institute
⁷ Frederick National Laboratory for Cancer Research
⁸ Agios Pharmaceuticals
⁹ Eisai, Inc
¹⁰ Pfizer Inc
¹¹ EnClear Therapies
¹² Bristol Myers Squibb
¹³ Eli Lilly and Company
¹⁴ Pharmechanics, LLC
¹⁵ Luther College
¹⁶ InSphero AG
¹⁷ Quiver Bioscience
¹⁸ Promega Corporation
¹⁹ Beth Israel Deaconess Medical Center
²⁰ TetraScience
²¹ Revvity, Inc.
²² QualSci Consulting, LLC
²³ Merck & Co., Inc.

No abstract available

Sections